Pre-feasibility Study for Establishing Radioisotope and Radiopharmaceutical Production Facilities in Developing
Efrain Araujo Perini1, Mikhail Skopchenko2, Tran Thu Hong3
1Institute of Energy and Nuclear Research (IPEN), Av. Prof. Lineu Prestes 2242, Cidade Universitaria., 05508-000, Sao Paulo, SP, Brazil.
Current Radiopharmaceuticals
|March 30, 2019
Summary
Access to essential medical radioisotopes and radiopharmaceuticals is globally unbalanced, with many developing nations lacking production facilities. Establishing these capabilities requires significant investment but offers substantial benefits through technology transfer.
Area of Science:
- Nuclear Medicine
- Radiopharmaceutical Production
- Medical Isotopes
Background:
- Many developing countries lack essential infrastructure for producing medical radioisotopes and radiopharmaceuticals.
- Global access to these life-saving medical supplies is unevenly distributed.
Purpose of the Study:
- To analyze the global imbalance in access to medical radioisotopes and radiopharmaceuticals.
- To identify key challenges and support mechanisms for developing countries entering this field.
Main Methods:
- Data compilation from International Atomic Energy Agency (IAEA) and World Health Organization (WHO) databases.
- Information gathering through direct engagement with global nuclear medicine professionals.
- Review of pertinent scientific literature.
Main Results:
- Significant financial and human resources are necessary for establishing radioisotope and radiopharmaceutical production capabilities.
- International organizations like the IAEA offer support for developing countries aiming to build production infrastructure.
Conclusions:
- The worldwide distribution of medical radioisotope and radiopharmaceutical infrastructure is significantly unbalanced.
- Technology transfer is crucial, providing immediate patient benefits and fostering regional economic growth and employment.
Related Concept Videos
01:28Isotopes and Radioisotopes
11.4K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
An isotope containing...
11.4K
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
211
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
211
02:01pre-mRNA Processing
57.3K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.3K
01:35Pre-mRNA Processing: Modification of pre-mRNA Ends
14.3K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
14.3K
02:41Chromatin Structure Regulates pre-mRNA Processing
8.1K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
8.1K
01:16Tracheostomy Care I: Pre-procedural Steps
1.1K
A tracheostomy is a surgical technique that involves making an incision in the neck to provide access to the trachea. It is frequently used in medical conditions such as airway obstruction and prolonged mechanical ventilation. Effective nursing management is crucial for the long-term success of a tracheostomy.
Required Equipment
The equipment necessary for tracheostomy care includes:
Required Equipment
The equipment necessary for tracheostomy care includes:
1.1K